# Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients

> **NCT07725484** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 1526 (estimated)

## Conditions studied

- Heart Failure Due to Coronary Artery Disease

## Interventions

- **DRUG:** Alpha-Lipoic Acid (ALA)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07725484
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-01
- **Primary completion:** 2030-11-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 1526 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725484, "Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07725484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*